Navigation Links
Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva
Date:12/21/2009

of the upfront monies paid. This constitutes 30% of the $20 million license fee and 30% of the premium on Teva's equity investment in OncoGenex as well as a portion of the $30 million prepaid development costs that OncoGenex will subsequently contribute to the development of OGX-011. Isis will also receive 30% of the up to $370 million in milestone payments OncoGenex is eligible to receive in addition to 5.5 - 7% royalties on all sales of OGX-011.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 21 drugs in development. Isis' drug development programs are focused on treating cardiovascular, metabolic and severe neurodegenerative diseases and cancer. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics. Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide. Additional information about Isis is available at www.isispharm.com.

ISIS FORWARD LOOKING STATEMENT

This press release includes forward-looking statements regarding Isis' business, its collaboration with OncoGenex Pharmaceuticals, its financial and business development activities, and the develo
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay(TM)
2. Vion Pharmaceuticals Files for Chapter 11 Bankruptcy
3. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
4. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
5. Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
6. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
7. Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration
8. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
9. Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program
10. China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009
11. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 Medical Tracking Solutions, Inc., ... hiring of Brian Timberlake as Senior ... efforts and build relationships with existing and new ... development, sales, and sales management as well as ... is a comprehensive inventory management system that provides ...
(Date:3/3/2015)... LOUISVILLE, Ky. , March 3, 2015 ... Louisville,s greatest leaders in aesthetics. In ... successful Brownsboro Plastic and Hand Surgery practice, Dr. Cummins ... Louisville Tattoo Removal clinic . Dr. Cummins performs ... "I founded Louisville Tattoo Removal in order ...
(Date:3/3/2015)... 3, 2015   ... patients respectively Publications in peer reviewed journals ... Gastroenterology highlight diagnostic value of confocal laser endomicroscopy ... and across Asia ... MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser ...
Breaking Medicine Technology:Medical Tracking Solutions, Inc. Hires New SVP, Sales 2Surgeon Owned And Operated Louisville Tattoo Removal Offers Astanza Duality Laser Treatments 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4
... PLC,(OTC Bulletin Board: SNKTY), a life sciences company ... science of healthy aging,announced today the launch of ... information to consumers and medical,professionals about Pyratine-6, Senetek,s ... The website ( http://www.Pyratine-6.com ) is a comprehensive ...
... PARK, Ill., Jan. 26 Data published ... pivotal trial evaluating the,XIENCE V(TM) Everolimus Eluting Coronary ... the TAXUS(R) Express2(TM),Paclitaxel-Eluting Coronary Stent System (TAXUS) in ... In the SPIRIT III trial of 1,002,patients, ...
Cached Medicine Technology:Senetek PLC Launches Dedicated Pyratine-6(TM) Website 2Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent 2Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent 3Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent 4Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent 5
(Date:3/3/2015)... (PRWEB) March 03, 2015 The biggest ... set to reveal the world’s first fully integrated air ... breathing and controls an air purifier to remove dust, ... informed, and in control, via phone, tablet or computer. ... in over 50 countries worldwide, will unveil its Internet-enabled ...
(Date:3/3/2015)... March 03, 2015 Today the Brain ... maker of bike, skate, snow, water, and motorcycle helmets, ... brain injury. The partnership kicks off with Nutcase donating ... http://www.nutcasehelmets.com to BIAA during the month of ... Each year BIAA leads the nation in observing Brain ...
(Date:3/3/2015)... 2015 The report “Alopecia – Pipeline ... development for Alopecia. Alopecia is the loss of hair. ... types of alopecia. Causes for alopecia include aging, genetics, ... may include male pattern hair loss, female diffuse hair ... be classified as focal or diffuse and by the ...
(Date:3/3/2015)... it is clear that the prospect of reduced premiums ... signing up to UBI policies, more mature audiences may ... to current regulations, the application of UBI in Canada ... capability is starting to be realised in the US ... are at the top of the value-added services wish-list. ...
(Date:3/3/2015)... Topical BioMedics, Inc., announces its March Pain Management Workshop ... March 10th, 12pm – 1pm and 4pm to 5pm. ... , The Pain Management Workshops are free and ... workshop is “Opioid Addiction: An Over-Medicated Society.” It’s ... of the world’s population, yet consumers 99% of the world’s ...
Breaking Medicine News(10 mins):Health News:Smart sensor and air purifier interconnect to track and trap dust, pollen and dangerous particles in home and workplace air 2Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5
... Compassionate Runner, Linda Quirk, Announces Goal of Raising One Million, Dollars ... ... 16 At 55, Linda Quirk is about to embark,on an ... trek across the globe by running next week,s Boston Marathon. The,goal ...
... Downtime in the Spring to Receive Cosmetic Surgery, ... so,does the desire to look good in that swimsuit. ... in early spring in order to ready,themselves for the ... liposuction. Patients know,that it takes weeks and months for ...
... Mike Roban has been named Vice,President of Sales ... the worldwide emergency assistance and insurance company.,A respected veteran ... health,and travel assistance services, Roban will add further depth ... Prior to joining MEDEX Global Group, Roban was the ...
... More than 40 Tier 3 Drugs for Chronic Diseases ... According to a New Report from HealthLeaders-InterStudy, ... managed care market intelligence, reports that Blue,Cross and Blue ... campaign as of January 2008 in which it waives ...
... score high on intelligence tests are also good at ... carried out the study also suspect that accuracy in ... problem solving and reasoning. , Researchers at the ... demonstrated a correlation between general intelligence and the ability ...
... JACKSONVILLE, Fla. Two new international studies by researchers ... out the notion that Parkinsons disease is largely caused ... related generations over hundreds, if not thousands of years. ... or large and causative, overturn common beliefs that the ...
Cached Medicine News:Health News:55-Year-Old Grandmother to Document Journey of Running Seven Marathons on Seven Continents on Run7on7.com 2Health News:55-Year-Old Grandmother to Document Journey of Running Seven Marathons on Seven Continents on Run7on7.com 3Health News:Getting Beach Ready Calls for More Than Hitting the Gym 2Health News:MEDEX Global Group Hires Industry Veteran Mike Roban as Vice President of Sales 2Health News:Blue Cross Blue Shield of North Carolina Implements Aggressive Generic Medication Campaign 2Health News:Different mutations in single gene suggest Parkinson's is primarily an inherited genetic disorder 2Health News:Different mutations in single gene suggest Parkinson's is primarily an inherited genetic disorder 3Health News:Different mutations in single gene suggest Parkinson's is primarily an inherited genetic disorder 4Health News:Different mutations in single gene suggest Parkinson's is primarily an inherited genetic disorder 5
... OPTIMA Laser System is designed to induce ... a near infrared laser source. When used ... delivers a controlled level of laser energy ... temperature range where tissue necrosis rapidly occurs, ...
... Diode Laser Series, including the Ceralas D ... soft-tissue applications in medical, dental, and veterinary ... hemoglobin, the 980 nm laser series allow ... field for most surgical procedures. Unlike other ...
... portable AccuPach V Pachymeter from Accutome Inc. features ... synthesized voice that announces readings aloud. It uses ... has an optional printer that records the date ... pressure into the unit and it will provide ...
... monoclonal antibody based colorimetric test intended ... gonorrhoeae. The test requires less than ... heating or pretreatment. The test does ... cultures. GonoGen&trade II eliminates agglutination, guesswork, ...
Medicine Products: